GABA Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GABA Therapeutics's estimated annual revenue is currently $1.1M per year.(i)
  • GABA Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • GABA Therapeutics has 7 Employees.(i)
  • GABA Therapeutics grew their employee count by 0% last year.

GABA Therapeutics's People

NameTitleEmail/Phone
1
CEO & CMOReveal Email/Phone
2
VP ChemistryReveal Email/Phone
3
RegulatoryReveal Email/Phone
4
Business AdvisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is GABA Therapeutics?

GABA Therapeutics is developing GRX-917, an anxiety medication as effective as benzodiazepines like Xanax, but with minimal to no side effects. The drug’s dual mechanism of action may also benefit a broad range of neuropsychiatric and neurological disorders.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M717%N/A
#2
$0.5M70%N/A
#3
$0.5M70%N/A
#4
$0.5M7-76%N/A
#5
$1.8M7-30%N/A